position： EnglishChannel > Experts in China> Russian Experts Seek TCM Collaboration

Russian Experts Seek TCM Collaboration

Source: Science and Technology Daily | 2023-11-21 15:59:59 | Author: Science and Technology Daily

By LONG Yuemei & BAI Wenlong

The Russian Experts experience the process of making the Angongniuhua. (PHOTO: LONG Yuemei/S&T Daily)

A Russian delegation headed by scientist Tupolev Valerii, vice-president of the Russian Academy of Engineering, visited Guangzhou Pharmaceutical Holdings Limited (GPHL) on November 18 to explore ways to conduct sci-tech exchanges.

"It is great to see that GPHL is integrating traditional Chinese medicine (TCM) production with advanced digital technology," Valerii said. The experts gained insight into intelligent production lines for TCM and the technique of producing Angong Niuhuang, a Chinese medicine used to treat acute cerebrovascular diseases.

Remarking on the significant changes in China over the past 15 years, Valerii highlighted the broad collaboration potential between the Russian Academy of Engineering (RAE) and GPHL in the fields of TCM and pharmaceutical equipment production and technology. He also called for more talent exchanges, sci-tech cooperation and sci-tech achievement transformation.

To speed up the innovation process of TCM, GPHL has initiated the TCM Industry Technology Innovation Strategic Alliance. In June, Li Chuyuan, chairman of GPHL , was elected as a foreign academician of the Russian Academy of Engineering. Li said he will foster exchanges and cooperation between Chinese and Russian medical science and industry.

Editor：龍?jiān)?

Top News

Tech-Finance Synergy Unlocks Innovation Potential

?Thanks to strong policy support, a favorable market environment and a sound innovation ecosystem, the virtuous cycle of tech, capital and industry is gaining greater momentum in China.

Jointly Protecting People's Rights in Digital Era

?Emerging technologies like AI, big data and the Internet of Things are rapidly reshaping the world in this era of digital intelligence. However, they are also bringing challenges to human rights, which makes joint efforts essential. Science and Technology Daily spoke with international experts on these issues against the backdrop of the 2025 China-Europe Seminar on Human Rights hosted by the China Society for Human Rights Studies and Cátedra China Foundation in Madrid, Spain, on June 25 on the theme "Human Rights in the Era of Digital Intelligence."

First Human Clinical Trial of Invasive BCI in China

A major breakthrough in neurotechnology has been achieved with the successful completion of China's first-in-human clinical trial of an invasive brain-computer interface (BCI) system. With that China becomes the second country in the world to reach the clinical stage in this field.